Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats.
In the current study, interstitial fluid (ISF), bradykinin (BK), and angiotensin II (ANG II) levels were measured using cardiac microdialysis in conscious, nonsedated rats at baseline and at 48 h and 5 days after each of the following: sham surgery (sham, n = 6), sham + administration of ANG-converting enzyme inhibitor ramipril (R, n = 6), creation of aortocaval fistula (ACF, n = 6), ACF + R (n = 6), and ACF + R + BK2 receptor antagonist (HOE-140) administration (n = 6). At 5 days, both ISF ANG II and BK increased in ACF rats (P < 0.05); however, in ACF + R rats, ISF ANG II did not differ from basal levels and ISF BK increased greater than threefold above baseline at 2 and 5 days (P < 0.05). Five days after ACF, the left ventricular (LV) weight-to-body weight ratio increased 30% (P < 0.05) in ACF but did not differ from sham in ACF + R and ACF + R + HOE-140 rats despite similar systemic arterial pressures across all ACF groups. However, ACF + R + HOE-140 rats had greater postmortem wall thickness-to-diameter ratio and smaller cross-sectional diameter compared with ACF + R rats. There was a significant increase in mast cell density in ACF and ACF + R rats that decreased below sham in ACF + R + HOE-140 rats. These results suggest a potentially important interaction of mast cells and BK in the cardiac interstitium that modulates the pattern of LV remodeling in the acute phase of volume overload.
Wei
Chih-Chang
CC
Department of Medicine, Division of Cardiovascular Disease, Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA.
Lucchesi
Pamela A
PA
Tallaj
Jose
J
Bradley
Wayne E
WE
Powell
Pamela C
PC
Dell'Italia
Louis J
LJ
D000208:Acute Disease; D000804:Angiotensin II / Q000097:blood / Q000378:metabolism; D000818:Animals; D001011:Aorta; D001164:Arteriovenous Fistula; D001920:Bradykinin / Q000097:blood / Q000378:metabolism*; D002306:Cardiac Volume / Q000502:physiology; D002452:Cell Count; D053818:Chymases; D003243:Consciousness; D004195:Disease Models, Animal; D005110:Extracellular Space / Q000378:metabolism; D008407:Mast Cells / Q000166:cytology / Q000378:metabolism*; D017551:Microdialysis; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012697:Serine Endopeptidases / Q000378:metabolism; D014682:Vena Cava, Inferior; D020257:Ventricular Remodeling / Q000502:physiology*
D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D012697:Serine Endopeptidases; D053818:Chymases; D001920:Bradykinin